Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)
- First Posted Date
- 2018-10-18
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Da Volterra
- Target Recruit Count
- 260
- Registration Number
- NCT03710694
- Locations
- 🇷🇴
Spitalul Clinic de Boli Infecţioase şi Tropicale Dr. Victor Babeş, Secţia Pneumologie II, Bucuresti, Romania
🇷🇴Institutul de Pneumoftiziologie "MariusNasta" (Pavilionul IV), Sectia Pneumologie VII, Bucuresti, Romania
🇧🇬Hosp Ruse EOOD, Ruse, Bulgaria
Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- Da Volterra
- Target Recruit Count
- 150
- Registration Number
- NCT02917200
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
Safety and Efficacy Study of DAV132 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- Da Volterra
- Target Recruit Count
- 44
- Registration Number
- NCT02176005
- Locations
- 🇫🇷
CLINICAL INVESTIGATION CENTER (CIC), Groupe Hospitalier Bichat-Claude Bernard, Paris, France
Multi-Antibiotic Resistance Carriage in Gut Flora
Completed
- Conditions
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Da Volterra
- Target Recruit Count
- 272
- Registration Number
- NCT01591538
- Locations
- 🇫🇷
Centre d'épidémiologie et de santé publique des armées, Saint Mandé cedex, France
© Copyright 2024. All Rights Reserved by MedPath